Home › Neurologic Diseases › Texas › San Antonio
Neurologic Diseases clinical trials in San Antonio, TX
4 studies for Neurologic Diseases are looking for participants at sites in and around San Antonio (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
RecruitingPhase 2/3
- San Antonio, Texas, San Antonio
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
RecruitingPhase 2
- The University of Texas Health Science Center, San Antonio
Product Surveillance Registry
RecruitingObservational study
- San Antonio, San Antonio
Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
RecruitingPhase 1/2
- The Cancer Therapy and Research Center at UTHSCSA, San Antonio
About Neurologic Diseases
Your nervous system includes your brain, spinal cord, and nerves. Learn about neurologic diseases, including their symptoms, causes, and treatments.
More about Neurologic Diseases on MedlinePlus
Neurologic Diseases trials in other cities
- Boston, MA10 studies
- Washington, DC8 studies
- Miami, FL7 studies
- Philadelphia, PA7 studies
- Orlando, FL7 studies
- Dallas, TX7 studies
- St. Louis, MO6 studies
- Houston, TX6 studies
- San Diego, CA6 studies
- New York City, NY6 studies
- Chicago, IL6 studies
- Pittsburgh, PA5 studies
Other studies in San Antonio
- Non-Small Cell Lung Cancer59 studies
- Colorectal Cancer46 studies
- Breast Cancer46 studies
- Metastatic Cancer44 studies
- Cancer (all types)41 studies
- Obesity40 studies
- Type 2 Diabetes37 studies
- Overweight34 studies
- Ovarian Cancer31 studies
- Pancreatic Cancer31 studies
- Prostate Cancer28 studies
- Endometrial Cancer27 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.